Diseases, Conditions, Syndromes

Making the case for intranasal COVID-19 vaccines

A microbiologist and an immunologist from the University of Alabama at Birmingham have published a Perspective piece in the journal Science outlining the possible benefits of developing COVID-19 vaccines delivered in an intranasal ...

Medical research

Stanford developing single-dose nanoparticle vaccine for COVID-19

Before the pandemic, the lab of Stanford University biochemist Peter S. Kim focused on developing vaccines for HIV, Ebola and pandemic influenza. But, within days of closing their campus lab space as part of COVID-19 precautions, ...

Diseases, Conditions, Syndromes

What should a successful SARS-CoV-2 vaccine do?

A lot has been written recently about the merits of different potential vaccines for SARS-CoV-2. "Merit" is generally assumed to mean that the vaccine will make us immune. But what, exactly, is immunity, and how would we ...

Diseases, Conditions, Syndromes

A more affordable, lower-risk polio vaccine may be on the horizon

University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine using virus-like particles (VLPs). These particles mimic the outer protein shell of poliovirus, but ...

Diseases, Conditions, Syndromes

Strep A vaccine progress: New antibody discovery fuels development

Researchers have discovered how antibodies help to protect against contagious bacterial infections caused by Strep A, including strep throat. And the findings are already contributing to efforts to accelerate the development ...

page 6 from 40